In this article, we combined the four-gene based riskScore with clinical risk factors to construct a nomogram to assess the probability of 3- and 5- year DFS for patients with ER+ and HER2- early stage invasive breast cancer in TCGA-BRCA dataset. Here, ESR1 is linked to invasive breast carcinoma.